Arcadia Biosciences Cash Flow - Quarterly (NASDAQ:RKDA)

Add to My Stocks
$1.16 $0.04 (3.33%) RKDA stock closing price Dec 08, 2016 (Closing)

The Arcadia Biosciences cash flow statement is one of the three reports that the company generates every quarter. The profit-loss statement shows Arcadia Biosciences profits, the balance sheet shows Arcadia Biosciences debt, and the cash flow statement reflects the liquidity and solvency of a firm. This statement reflects the company's ability to generate cash flows. The cash flow statement is essetial while conducting the Arcadia Biosciences cash flow analysis and can be used to measure the operating performance of Arcadia Biosciences compared to various industry peers like ANDE stock and YONG stock. Arcadia Biosciences has a negative cash and cash equivalents change of $-13.5M. View details of Arcadia Biosciences cash flows for latest & last 40 quarters.

show more
Annual
Quarterly
View Previous Quarters
View Next Quarters
Fiscal year is Jan - Dec. 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2
Arcadia Biosciences Net Income Cash Flow
-13.91M-9.74M-5.19M-17.95M-14.09M-9.48M-5.8M-18.33M-16.35M-9.28M
Depreciation Depletion Amortization Cash-Flow0.34M0.28M0.14M0.37M0.21M0.14M0.07M0.35M0.27M0.18M
Net Increase (Decrease) in Assets Liabilities-0.01M0.11M-0.07M-0.05M0.52M0.81M1.2M-1.33M-0.08M-0.85M
Cash From (used in) Discontinued Operations----------
Other Adjustments Net0.8M0.49M0.26M2.52M2.2M1.93M1.92M4.53M4.03M1.53M
Arcadia Biosciences Net Cash from (used by) Operating Activities
-12.77M-8.84M-4.85M-15.1M-11.16M-6.58M-2.59M-14.78M-12.12M-8.42M
Increase (Decrease) in Prop Plant And Equipment-0.22M-0.19M-0.13M-0.14M-0.08M-0.02M-0.01M-0.14M-0.03M-
Acquisition Disposition of Subsidiaires--------1.45M-1.45M-0.95M
Increase (Decrease) in Investments-0.88M12.2M10.46M-46.21M-11.29M-----
Other Cash Inflow (Outflow) from Investment Activities----------
Arcadia Biosciences Net Cash from (used by) Invesment Activities
-1.1M12M10.32M-46.36M-11.37M-0.02M-0.01M-1.59M-1.48M-0.94M
Issuance (Purchase) of Equity Shares0.42M0.27M0.13M68.58M68.39M68.25M-32.86M32.85M32.84M
Issuance (Repayment) of Debt Securities---10.2M8.87M8.87M-1.45M-1.15M-0.89M-0.63M
Increase (Decrease) in Bank & Other Borrowings----------
Payment of Dividends & Other Cash Distributions----------
Other Cash from (used by) Financing Activities-0.04M-0.04M-0.04M-9.92M-8.34M-7.09M-1.23M-1.59M-0.01M-
Arcadia Biosciences Net Cash from (used by) Financing Activities
0.38M0.22M0.09M68.87M68.92M70.03M-2.68M30.11M31.94M32.21M
Effect of Exchange Rate Changes on Cash----------
Arcadia Biosciences Net Change in Cash & Cash Equivalents
-13.5M3.38M5.56M7.4M46.39M63.43M-5.29M13.73M18.33M22.84M
Cash & Equivalents at Beginning of Year16.57M2.83M5.35M-------
Cash & Equivalents at Year End10.47M27.36M29.54M23.97M62.96M80M11.27M16.57M21.17M25.67M
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Quarters
View Next Quarters
Get Cash flow for another ticker

Arcadia Biosciences stock comparison chart provides an easy way to compare the stock price with peers along with details of Arcadia Biosciences stock price history.
The statement of cash flows can be categorized into three main sections:
  • Net Change in Cash and Cash Equivalents: Arcadia Biosciences cash reduced QoQ to $-13.91M, meaning the company is unable to meet its expenditure and grow cash which will also eventually reflect in the Arcadia Biosciences stock price movement.
  • Arcadia Biosciences decreased its cash from operating activities to $3.93M in 2016-Q3. Operating activities include production of goods or creating a product or providing a service, and collecting payment for the same from customers. The cash generated from these activities is refered to as cash flow from operating activities.
  • Cash from investing stood at a negative value of $-1.1M for RKDA stock. A company with surplus cash usually thinks of re-investing it in the form of buying fixed assests, or purchasing plant/ machinery which will help grow the business further. By looking at cash flow from investment activities one can check where the company is putting its cash.
  • Inflow of cash in the form of bank loans and shareholders equity, and outflow of cash because of dividend payments, share repurchase payments etc. come under financing activities. The cash generated from these activities was $0.38M for Arcadia Biosciences.
.

Key Financial Ratios For Arcadia Biosciences Cash Flow

FCF margin
-3.67